• 

  Biomarkers Say COVID-19 Brain Damage Is Like Alzheimer’s, But Faster
• 

  COVID Brain Fog? These 6 Things Can Help
• 

  New Era for Alzheimer’s Trials: Blood Tests Bring Younger Participants
• 

  Could Too Much Coffee Shrink Your Brain? (And Would It Matter?)
• 

  New Alzheimer’s Prediction Smartphone App Gets FDA Breakthrough Status
• 

  Medicare Is Deciding Now Whether To Cover Aduhelm—And All the Similar Drugs to Follow
• 

  FDA Speeds Up Process for Two More Anti-Amyloids
• 

  What is an Aduhelm Infusion, and Why Was Its Approval So Controversial?
• 

  What Is Aduhelm and How Does It Fight Alzheimer’s?
• 

  Dementia Advocates: Congress Should Triple Funding for Alzheimer’s Program
• 

  13 New Gene Variants Linked to Alzheimer’s in Pioneering Genome Study
• 

  Pimavanserin Snag: FDA Rejects Acadia’s Dementia Psychosis Drug
• 

  Study: Recovering From Loneliness Even Better for the Brain Than Never Being Lonely
• 

  Could Arthritis Drug Olumiant Treat Alzheimer’s? A.I. Thinks So
• 

  What’s Next for Eli Lilly Alzheimer’s Drug Donanemab? Trial Enrollment Continues

Previous234Next